DAR ZAVAIN received a stock award from RECURSION PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/2/2026ACC: 0001601830-26-000092
Director
Since Apr 2021
+5.11K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
5.11K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+5.11K
Price / share
—
Trade value
—
% of position
2.2%
7/1/2026
235.66K→240.76K
Total
Net shares
+5.11K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 7/1/2026 | A · Award | +5.11K | — | — | 2.2% | 235.66K | 240.76K |
| Total | +5.11K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported